ARTICLE | Company News
Helmholtz Association, Spero Therapeutics deal
March 23, 2015 7:00 AM UTC
Helmholtz Association’s tech transfer partner, Ascenion, granted Spero exclusive rights to develop and commercialize anti-Pseudomonas aeruginosa compounds. Helmholtz is eligible to receive milestone a...